mercredi 11 octobre 2017

Onco Actu du 11 octobre 2017

1. Biologie

Study uncovers mutation that supercharges tumor-suppressor [Stanford Medicine]

Study Raises Questions About Patient-Derived Xenografts [The Scientist]

3.3 Prévention - Vaccins

Merck's Gardasil 9 offers at least 6 years of cancer protection, data show [FiercePharma]

5. Traitements

Extensive Lymph Node Removal Doesn't Improve Survival in Some Women with Early-Stage Breast Cancer [NCI]

5.12.7 Immunothérapies - vaccins

AbbVie bags option on Turnstone oncolytic virus candidates [FierceBiotech]

AbbVie and Turnstone Biologics Announce Global Collaboration on Viral Immunotherapies in Oncology [AbbVie]

5.2 Pharma

Eli Lilly Drug Fails in Lung Cancer, Stalling Oncology Strategy [Xconomy]

Lilly's breast cancer drug fails to help lung patients [Reuters]

5.2.1 Pharma - Partenariats

Broad Institute and Deerfield Management launch innovative partnership to tackle serious unmet medical needs [Broad Institute]

Deerfield commits $50M-plus to translational drug R&D at the Broad [EndPoints]

MedImmune and GamaMabs enter licensing agreement to develop antibody drug conjugate targeting cancer [MedImmune]

5.4 Traitements - Economie

Cancer-Drug Prices Are at a Tipping Point [Bloomberg]

6. Lutte contre les cancers

OHSU lures prominent cancer scientist from MD Anderson Cancer Center in Houston [OregonLive]

Pharma's Puerto Rico problems could mean drug shortages: FDA chief [Reuters]

6.6 Publications

Publishers threaten to remove millions of papers from ResearchGate [Nature]

6.9 Controverses

Is Precision Medicine Possible? [Issues in Science and Technology]